|  In
their ongoing efforts to understand the mechanism
of depression of FMRP synthesis by the expanded
(CGG) tract, and to seek reagents that may alleviate
this block, Dr. Mickey Fry, a longtime CFXF researcher
at the Technion-Israel Institute for Technology,
and his team of scientists, have established a
collaboration with Dr. Paul Hagerman of the University
of California, Davis, School of Medicine. A graduate
student in the Hagerman lab, Anna Ludwig, has
been developing vectors to study the regulation
of translation. She and Dr. Hagerman generously
agreed to provide these vectors to Dr. Fry as
part of a collaborative effort. The scientists
feel that this may be a most fruitful project
and are very eager to launch it using the reagents
developed by the Hagerman lab. Dr. Fry and his
long time associate, Dr. Pnina Weisman-Shomer,
and a bright and productive MD/PhD student, Samer
Khateb will be working on this project in Israel.
We are delighted to see this type of efficient
international cooperation among fragile X researchers.
CFX works at all levels to stress the importance
of this type of collaboration as a critical component
to the search for a cure for Fragile X. We wish
Drs. Fry and Hagerman well and know they will
inform us of their progress. |